Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Liver Histology: Diagnostic and Prognostic Features.

Literature DB >> 31753251

Liver Histology: Diagnostic and Prognostic Features.

Abstract

When patients with suspected drug-induced liver injury (DILI) undergo liver biopsy, the pathologist can provide a wealth of information on the morphologic changes. The most common histologic patterns of DILI include mimics of acute and chronic hepatitis as well as acute cholestasis, chronic cholestasis, and a mixed pattern that combines hepatitis with cholestasis. The pattern may suggest etiologies of injury or correlate with reported patterns of injury for specific agents. Biopsy may exonerate or indict particular drugs as causal agents of injury and provide specific information on severity of injury and specific types of changes related to various outcomes. Published by Elsevier Inc.

Entities: Chemical Disease Gene Species

Keywords: Acute hepatitis; Cholestatic hepatitis; Hepatic necrosis; Hepatotoxicity; Nodular regenerative hyperplasia

Mesh：

Year: 2019 PMID： 31753251 PMCID： PMC6986808 DOI： 10.1016/j.cld.2019.09.004

Source DB: PubMed Journal: Clin Liver Dis ISSN： 1089-3261 Impact factor: 6.126

40 in total

1. Ipilimumab-associated Hepatitis: Clinicopathologic Characterization in a Series of 11 Cases.

Authors: Melanie Johncilla; Joseph Misdraji; Daniel S Pratt; Agoston T Agoston; Gregory Y Lauwers; Amitabh Srivastava; Leona A Doyle
Journal: Am J Surg Pathol Date: 2015-08 Impact factor: 6.394

2. Severe drug-induced liver injury associated with prolonged use of linezolid.

Authors: Liesbet De Bus; Pieter Depuydt; Louis Libbrecht; Linos Vandekerckhove; Joke Nollet; Dominique Benoit; Dirk Vogelaers; Hans Van Vlierberghe
Journal: J Med Toxicol Date: 2010-09

3. Clinical presentations and outcomes of bile duct loss caused by drugs and herbal and dietary supplements.

Authors: Herbert L Bonkovsky; David E Kleiner; Jiezhun Gu; Joseph A Odin; Mark W Russo; Victor M Navarro; Robert J Fontana; Marwan S Ghabril; Huiman Barnhart; Jay H Hoofnagle
Journal: Hepatology Date: 2017-02-07 Impact factor: 17.425

4. Nitrofurantoin-induced immune-mediated lung and liver disease.

Authors: A Schattner; J Von der Walde; N Kozak; N Sokolovskaya; H Knobler
Journal: Am J Med Sci Date: 1999-05 Impact factor: 2.378

5. Amiodarone inhibits the mitochondrial beta-oxidation of fatty acids and produces microvesicular steatosis of the liver in mice.

Authors: B Fromenty; C Fisch; G Labbe; C Degott; D Deschamps; A Berson; P Letteron; D Pessayre
Journal: J Pharmacol Exp Ther Date: 1990-12 Impact factor: 4.030

6. Isoniazid-associated hepatitis in 114 patients.

Authors: M Black; J R Mitchell; H J Zimmerman; K G Ishak; G R Epler
Journal: Gastroenterology Date: 1975-08 Impact factor: 22.682

Review 7. Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver.

Authors: Karima Begriche; Julie Massart; Marie-Anne Robin; Annie Borgne-Sanchez; Bernard Fromenty
Journal: J Hepatol Date: 2010-11-17 Impact factor: 25.083

Review 3. Detailed Molecular Mechanisms Involved in Drug-Induced Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: An Update.

Authors: Laura Giuseppina Di Pasqua; Marta Cagna; Clarissa Berardo; Mariapia Vairetti; Andrea Ferrigno
Journal: Biomedicines Date: 2022-01-17

3 in total

Liver Histology: Diagnostic and Prognostic Features.

1. Ipilimumab-associated Hepatitis: Clinicopathologic Characterization in a Series of 11 Cases.

2. Severe drug-induced liver injury associated with prolonged use of linezolid.

3. Clinical presentations and outcomes of bile duct loss caused by drugs and herbal and dietary supplements.

4. Nitrofurantoin-induced immune-mediated lung and liver disease.

5. Amiodarone inhibits the mitochondrial beta-oxidation of fatty acids and produces microvesicular steatosis of the liver in mice.

6. Isoniazid-associated hepatitis in 114 patients.

Review 7. Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver.

8. Development of an accurate index for predicting outcomes of patients with acute liver failure.

9. Hepatic injury associated with diphenylhydantoin therapy. A clinicopathologic study of 20 cases.

10. Substantial hepatic necrosis is prognostic in fulminant liver failure.

Review 1. Nucleic acids and proteins carried by exosomes from various sources: Potential role in liver diseases.

2. The Utility of Liver Biopsy in the Evaluation of Liver Disease and Abnormal Liver Function Tests.

Review 3. Detailed Molecular Mechanisms Involved in Drug-Induced Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: An Update.